![](/img/cover-not-exists.png)
Phase I open-label study of afatinib plus vinorelbine in patients with solid tumours overexpressing EGFR and/or HER2
Bahleda, Rastislav, Varga, Andrea, Bergé, Yann, Soria, Jean-Charles, Schnell, David, Tschoepe, Inga, Uttenreuther-Fischer, Martina, Delord, Jean-PierreLanguage:
english
Journal:
British Journal of Cancer
DOI:
10.1038/bjc.2017.436
Date:
January, 2018
File:
PDF, 438 KB
english, 2018